The Reproductive Medicine Center at HKU-Shenzhen Hospital is one of the Hospital’s flagship Centers of Excellence.The Reproductive Medicine Center was founded by Professor Pak Chung Ho, Professor William S. B. Yeung, and Professor Ernest H. Y. Ng from the Obstetrics and Gynaecology Department of the University of Hong Kong.

We provide diagnosis and treatment for the full spectrum of reproductive disorders: infertility, reproductive endocrinology, recurrent pregnancy loss and repeated implantation failure, female sexual dysfunction, premature ovarian insufficiency, fertility preservation, and male infertility and sexual dysfunction through a dedicated andrology clinic.

The Reproductive Medicine Center was officially certified for operation of human assisted reproductive technology in October 2016. It has continuously passed the review and validation for ten years, and started providing human assisted reproductive technology and services, including Artificial Insemination of the husband's sperm (AIH), conventional in vitro fertilization-embryo transfer (IVF, commonly known as "test tube baby") and Intracytoplasmic Sperm Microinjection (ICSI). The pregnancy rate of patients receiving IVF was on a par with that in the QMH Assisted Reproduction and Embryology Center. This result reflected the significant development of reproductive medicine and the establishment of the discipline in the hospital.

In terms of clinical strength, the RMC has 2 consultant doctors from Hong Kong, 1 consultant doctors, 2 associate consultant doctors, and 4 senior doctors from the Chinese mainland. The center has always adhered to the service concept of evidence-based diagnosis and treatment, advocating the natural approach of the Department of Obstetrics and Gynecology of the University of Hong Kong. It has benefited millions of families in Shenzhen and surrounding areas. While accomplishing the dream of childbirth for infertile patients, it also provides the initial guarantee for the safety of mothers and babies and family happiness.

As of December 2024, the RMC has published more than 100 SCI papers signed by the hospital, and has established and carried out 44 national, provincial, municipal, and bureau-level grants, receiving 86 million RMB in funding. The project entitled "The Molecular Basis of Ovarian Development and the Mechanism of Premature Ovarian Failure and the Application of New Methods for the Treatment of Female Infertility", as a project of the Shenzhen Overseas High-level Talent Team Program (Peacock Program), received funding of 30 million RMB.

The RMC is the supporting department of the "Shenzhen Key Laboratory of Fertility Regulation" and the Shenzhen "Sanming Project" team. It has held many international conferences on reproductive medicine for many years, led the establishment of the Guangdong-Hong Kong-Macao Greater Bay Area Ovarian Alliance, and has been selected as the "strongest department of reproductive medicine" in Guangdong Province in 2019 and 2021 for two consecutive four years by the big data platform. The RMC is the only place in this discipline of Shenzhen to be included in the list. In June 2020, the center was rewarded as a key cultivation discipline of reproductive medicine in Shenzhen.